James P. Sullivan, Ph.D.

VP, Pharmaceuticals Discovery

James Sullivan, Ph.D., is Vice President, Pharmaceuticals Discovery. In this role, he is responsible for AbbVie’s research efforts in a variety of diseases including cancer, Alzheimer’s disease, hepatitis C, renal disease, and arthritis. He oversees a global network of scientists that includes AbbVie researchers at sites in the United States, Europe, and China, and external research partners around the world. Dr. Sullivan is a member of the Pharmaceutical Executive Committee and is chair of the Scientific Governing Board for Abbvie. He is also an executive sponsor for the AbbVie Women in Science organization. Jim joined Abbott in 1991 and has held various positions in the discovery organization including leadership positions in CNS and pain research.

Jim has advanced more than 60 compounds into clinical development, has more than 130 scientific publications and is an inventor on 11 patents. He is an adjunct faculty member at Northwestern University of Chicago. He earned his bachelor's degree and Ph.D. in biochemistry from Trinity College in Dublin, Ireland, and conducted post-doctoral research in neurobiology at Northwestern University.